{"name":"MeiraGTx UK II Ltd","slug":"meiragtx-uk-ii-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AAV - CNGB3","genericName":"AAV - CNGB3","slug":"aav-cngb3","indication":"Leber congenital amaurosis","status":"phase_1"},{"name":"AAV OPTIRPE65","genericName":"AAV OPTIRPE65","slug":"aav-optirpe65","indication":"Leber congenital amaurosis","status":"phase_2"},{"name":"adeno-associated virus vector AAV- CNGA3","genericName":"adeno-associated virus vector AAV- CNGA3","slug":"adeno-associated-virus-vector-aav-cnga3","indication":"Other","status":"phase_1"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"AAV RPE65","genericName":"AAV RPE65","slug":"aav-rpe65","indication":"Leber congenital amaurosis","status":"phase_1"}]}],"pipeline":[{"name":"AAV - CNGB3","genericName":"AAV - CNGB3","slug":"aav-cngb3","phase":"phase_1","mechanism":"Gene therapy targeting the CNGB3 gene","indications":["Leber congenital amaurosis","Retinitis pigmentosa"],"catalyst":""},{"name":"AAV OPTIRPE65","genericName":"AAV OPTIRPE65","slug":"aav-optirpe65","phase":"phase_2","mechanism":"Gene therapy targeting RPE65","indications":["Leber congenital amaurosis","Retinitis pigmentosa"],"catalyst":""},{"name":"AAV RPE65","genericName":"AAV RPE65","slug":"aav-rpe65","phase":"phase_1","mechanism":"Gene therapy for RPE65-mediated inherited retinal dystrophy","indications":["Leber congenital amaurosis","Inherited retinal dystrophy"],"catalyst":""},{"name":"adeno-associated virus vector AAV- CNGA3","genericName":"adeno-associated virus vector AAV- CNGA3","slug":"adeno-associated-virus-vector-aav-cnga3","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNcDZzMHZBNjdhcVZ1WnItNVlNbjRzWWFJdDZ1MlhSLWR5cjRJbUxFWU5zaXBqV042aEU1NUEyTXlkelJyZjhYNTZES1VCTTRla1NGSXlOMGxGR2tTbHQzZEhHNXppenJCb2ZEa2hJa0pYOTFrazVNeHZkeFFFdEYtTFZLWlIwZjdlZVMxdGZERFQ2aVJEWU9QclBITlJhSnc?oc=5","date":"2025-11-10","type":"deal","source":"BioPharma Dive","summary":"Lilly picks up an eye gene therapy in deal with MeiraGTx - BioPharma Dive","headline":"Lilly picks up an eye gene therapy in deal with MeiraGTx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQ2hWcExCX0RiX0FRY1lDOTF5U1U4dzk1RnV2U2lyMHRMTGxNcEstNmFzREJNanAwQUNid0M1N09zODN5YUVyME5aZE1kbC1YUjlXTWthbm1Gb0hhc21DZUxIOTk3SmNwbF92Z1A3V3k0U3dYdGdmbFlyZE9BOGZjc0JsSWJwQi1aSTZ1VTl5MlRZQnJDZTZRLVVHTU5LQ2J6ZUpSQzhMeDFHQQ?oc=5","date":"2025-03-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"MeiraGTx and Hologen launch AI-backed gene therapy venture - Pharmaceutical Technology","headline":"MeiraGTx and Hologen launch AI-backed gene therapy venture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNdmp5OUVwd2FIRERDeEhZcDBCbzU0NFdHS25TQWdfZnhSaVFfbW9YUkI5YTFuYUt5YnpjczZrZ0l1Sng3dDllNlJKS0FpZjEzUWxFVzdyT1Fpc1YzLXJZWWh2S1ZfOWp4aDhZWGNSMndxN2Eydmg1aTRjc1kxY1p6NERFWUU4aFNOczFOeWtKWHJfUERPeU0wdldISmo4cnZHdmZ2M24xSUQzVTNUZTVNTVhYOA?oc=5","date":"2025-03-13","type":"trial","source":"Fierce Biotech","summary":"Hologen AI commits up to $430M to help take MeiraGTx's Parkinson's gene therapy through phase 3 and beyond - Fierce Biotech","headline":"Hologen AI commits up to $430M to help take MeiraGTx's Parkinson's gene therapy through phase 3 and beyond","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOaXpfQ2N0RTd0STN3TjROVmhWWGJnSUltQm1fMjVEZkw1Q2JiaUVYMEt0ckNSVi1fRjlYZXk5WVIwX3M3Y0xEZFhGalhDM3d2MEVCS01sMmRQRlZ1ZUg2Z3g2LXJZNkwtRlJVTGQ0WFg1ZW5UOEF2eVB6QlNDNVNZS2xxUmxlbllmX2Z6UnpZN3RQVTAxZmhYcWhfdU1GX29zVGZmV3E4akY0RmNWaUNMWk5hSG9TMWlxVFNBVFdsMTRlYzg?oc=5","date":"2023-10-30","type":"pipeline","source":"Proactive Investors","summary":"MeiraGTx shares take off on $30M investment by Sanofi - Proactive Investors","headline":"MeiraGTx shares take off on $30M investment by Sanofi","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":3,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}